As the array of novel therapies for plaque psoriasis expands, a strategy to navigate treatment options is to focus on the specific needs of different patient groups, like Medicare-aged patients. ILUMYA® (tildrakizumab-asmn) is the only biologic for plaque psoriasis guaranteed to be covered under the medical benefit of Medicare, with no prior authorization and zero cost as a likely possibility. Join Dr Charles Turck and Dr John Koo as they share insights on the efficacy, safety, and accessibility of ILUMYA in this patient population. Dr. Koo is a Professor of Dermatology at the University of California at San Francisco School of Medicine.

Explore the latest breakthroughs in dermatology care with Dr. James Del Rosso, who highlights newly approved and emerging therapies for severe alopecia area, actinic keratosis, and atopic dermatitis. Dr. Del Rosso is the Research Director at JDR Dermatology Research, an Adjunct Clinical Professor of Dermatology at Touro University Nevada, and a practicing dermatologist in Las Vegas. He also presented on this topic at the 2025 Fall Clinical Dermatology Conference for Physician Assistants and Nurse Practitioners.

The underlying mechanisms behind chronic hand eczema (CHE) can lead to a variety of physical, emotional, social, and occupational challenges. To learn more about these challenges, Dr. Raj Chovatiya sits down with Dr. Benjamin Ehst to discuss what we currently know about the pathophysiology of CHE and what we can do to address patients’ unmet needs. Dr. Ehst is a dermatologist at Broadway Medical Clinic and an investigator at the Oregon Medical Research Center.

Chronic hand eczema (CHE) can have vast impacts on a patient’s personal and professional life, making the overall patient journey one of the most important considerations for clinicians. That’s why Dr. Jeff Yu joins Dr. Raj Chovatiya to share best practices for diagnosing and treating patients with CHE so we can optimize their journey. Dr. Yu is an Associate Professor at the Rosalind Franklin University Chicago Medical School.

Limited education, research, and access to care contribute to disparities in atopic dermatitis care among diverse populations. Hear from Dr. Ruchi Gupta, a Professor of Pediatrics and Medicine at Northwestern University Feinberg School of Medicine, as she discusses gaps in care among different racial and ethnic groups.

To ensure comprehensive care for atopic dermatitis, it’s essential to be aware of cultural differences and barriers to care in underserved populations. Dr. Ruchi Gupta, a Professor of Pediatrics and Medicine at Northwestern University Feinberg School of Medicine, highlights the need for increased awareness and collaboration between generalists and dermatologists to ensure better atopic dermatitis care.

The American Academy of Dermatology recently updated their guidelines regarding the treatment of moderate-to-severe atopic dermatitis to expand the recommended use of systemic therapies like biologics and JAK inhibitors. To help ensure our approach is up to date, Dr. Jennifer Caudle speaks with Dr. Steven Feldman about the new guidelines and how we can implement them into clinical practice. Dr. Feldman is a Professor of Dermatology, Pathology, Social Sciences and Health Policy at the Wake Forest University School of Medicine in Winston-Salem, North Carolina.

The American Academy of Dermatology recently updated the treatment guidelines for atopic dermatitis to include the latest systemic therapies, like biologics and JAK inhibitors. Since these new standards of care could offer improved outcomes for our patients with atopic dermatitis, Dr. Raj Chovatiya speaks with Dr. Christopher Bunick about what the new guidelines recommend and how we can incorporate them into clinical practice. Dr. Bunick is an Associate Professor of Dermatology at the Yale School of Medicine.

Pregnancy can trigger atopic dermatitis, with immune system shifts commonly contributing to skin issues. Dr. Jennifer Murase joins the program to explain the mechanisms behind pregnancy dermatoses and best practices for caring for patients, which she presented on at the 2024 Elevate Derm Conference. Dr. Murase is the Founder and Chair of the American Academy of Dermatology Women’s Health Expert Resource Group.

Patients’ adherence to psoriasis treatment, especially topical treatment, is often abysmal due to a variety of challenges and factors. That’s why Dr. Charles Turck speaks with Dr. Steven Feldman about these common challenges and how we can overcome them to improve adherence among our psoriasis patients. Dr. Feldman is a Professor of Dermatology, Pathology, Social Sciences, and Health Policy at the Wake Forest University School of Medicine in Winston Salem, North Carolina.